NCT07669636

Brief Summary

This prospective in vitro study aims to evaluate the effects of two chlorhexidine-based mouthwash formulations on the survival and function of human gingival fibroblasts (hGFs). Gingival fibroblasts obtained from discarded gingival tissue collected during routine dental procedures will be cultured and exposed to different concentrations of a conventional 0.2% chlorhexidine mouthwash and a 0.2% chlorhexidine mouthwash supplemented with N-acetylcysteine (NAC) and hyaluronic acid (HA). Cell viability, apoptosis, migration, and gene expression will be assessed at multiple time points using Trypan Blue exclusion assay, fluorescence-activated cell sorting (FACS), scratch assay, and quantitative real-time PCR. The study is designed to investigate the concentration-dependent effects of chlorhexidine on fibroblast viability and wound-healing-related functions and to determine whether the addition of NAC and HA may improve the biological compatibility of chlorhexidine-based formulations.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for all trials

Timeline
3mo left

Started Jul 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Jul 2026Nov 2026

First Submitted

Initial submission to the registry

June 20, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

June 25, 2026

Status Verified

June 1, 2026

Enrollment Period

3 months

First QC Date

June 20, 2026

Last Update Submit

June 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Human Gingival Fibroblast Viability

    Cell viability of human gingival fibroblast cultures exposed in vitro to different concentrations of chlorhexidine-based mouthwash formulations will be assessed using Trypan Blue exclusion assay and live/dead analysis by fluorescence-activated cell sorting (FACS). Viability will be expressed as the proportion of viable cells compared with total counted cells.

    24 hours, 3 days and 7 days from the start of cell culture exposure

Study Arms (1)

Healthy Adult Donors

Human Gingival Fibroblast Cultures

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population consists of three healthy adult donors undergoing routine dental surgical procedures at the Dental Unit of San Raffaele Hospital. Small fragments of discarded gingival tissue obtained during procedures such as tooth extraction or gingivectomy will be collected following informed consent. Human gingival fibroblasts will be isolated from these tissues and expanded in culture for in vitro experimental analyses.

You may qualify if:

  • Male or female adults aged 18 years or older.
  • Undergoing routine dental surgical procedures (e.g., tooth extraction or gingivectomy).
  • Willing and able to provide written informed consent for the use of discarded gingival tissue for research purposes.
  • Systemically healthy.

You may not qualify if:

  • Presence of systemic diseases.
  • Presence of relevant medical comorbidities.
  • Current smoker.
  • Refusal to provide informed consent for the use of discarded biological material.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Prospective in vitro laboratory study using primary human gingival fibroblasts isolated from discarded gingival tissue obtained from healthy adult donors. Fibroblast cultures will be exposed to different concentrations of chlorhexidine-based mouthwash formulations and evaluated over time for viability, apoptosis, migration, and gene expression.

Central Study Contacts

Roberto Professor Roberto Rotundo, Associate Professor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 20, 2026

First Posted

June 25, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

June 25, 2026

Record last verified: 2026-06